MAZE
Maze Therapeutics, Inc. Common Stock
NASDAQ: MAZE · HEALTHCARE · BIOTECHNOLOGY
$25.68
-1.04% today
Updated 2026-04-29
Market cap
$1.42B
P/E ratio
—
P/S ratio
501.65x
EPS (TTM)
$-3.05
Dividend yield
—
52W range
$8 – $54
Volume
0.9M
Maze Therapeutics, Inc. Common Stock (MAZE) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 5
Last 5 quarters
Avg EPS surprise
-27.1%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+96.5%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-13.3%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-35.3%
2026-03-25
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-25 | $-0.65 | +5.7% | $49.00 | $31.71 | -35.3% |
| 2025-11-06 | $-0.66 | -6.5% | $30.27 | $28.60 | -5.5% |
| 2025-08-12 | $-0.77 | -24.2% | $13.47 | $13.60 | +1.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.69 | $-0.65 | +5.7% | — | — |
| 2025-09-30 | $-0.62 | $-0.66 | -6.5% | — | — |
| 2025-06-30 | $-0.62 | $-0.77 | -24.2% | — | — |
| 2025-03-31 | $-0.63 | $-1.15 | -83.6% | — | — |
| 2024-12-31 | $0.45 | $-18.32 | -4171.1% | — | — |
Frequently asked questions
Has Maze Therapeutics, Inc. Common Stock beaten earnings estimates?
Maze Therapeutics, Inc. Common Stock has beaten Wall Street EPS estimates in 1 of its last 5 quarterly reports, with an average EPS surprise of -27.1% over the last 4 quarters.
How does MAZE stock react to earnings?
MAZE stock has moved an average of -13.3% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.